Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern
February 15, 2019 09:00 ET
|
Generex Biotechnology Corp.
Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology MIRAMAR, FL, Feb. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
Generex Announces Appointment of Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC Attorney
February 12, 2019 09:40 ET
|
Generex Biotechnology Corp.
- Veteran Securities Attorney Joins Management to Guide M&A Initiatives, SEC Regulatory Affairs, and Generex Up-listing MIRAMAR, FL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
Generex Biotechnology Responds to Demand for Payment
February 04, 2019 13:53 ET
|
Generex Biotechnology Corp.
- Challenges notice from Alpha Capital MIRAMAR, FL, Feb. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT)...
Generex Biotechnology Announces Investor Conference Call Scheduled for February 26, 2019
January 29, 2019 09:00 ET
|
Generex Biotechnology Corp.
Management to Provide Details on NuGenerex Immuno-Oncology: Dividend, New Acquisitions, IP Licensing Opportunities, and Strategic Plans for Public Listing Acquisition, Integration of Fuse...
Generex Launches DME-IQ, the “Smart Solution” for In-Office Management of Durable Medical Equipment
January 25, 2019 09:00 ET
|
Generex Biotechnology Corp.
-- Signs contract with The Orthopaedic Center of Tulsa, OK -- Expansion of end-to-end patient solutions with a customized software & service platform that will help increase compliance, optimize...
Generex Subsidiary NuGenerex Diagnostics Announces CE-Mark Certification for its Rapid Point-of-Care Express II Syphilis Treponemal Assay
January 24, 2019 09:00 ET
|
Generex Biotechnology Corp.
-- Rapid point-of-care syphilis assay -- Cleared for sale in the European Union -- Addressing the emerging global syphilis resurgence MIRAMAR, FL, Jan. 24, 2019 (GLOBE NEWSWIRE) -- via...
Generex Announces REVISED Record Date for NuGenerex Immuno-Oncology Stock Dividend
January 23, 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL , Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that...
Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans
January 22, 2019 10:00 ET
|
Generex Biotechnology Corp.
Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com)...
Generex Announces Record & Payment Dates for NuGenerex Immuno-Oncology Stock Dividend
January 16, 2019 14:10 ET
|
Generex Biotechnology Corp.
-- Share Dividend Declared -- One share of NuGenerex Immuno-Oncology for every 4 Shares of Generex Biotechnology MIRAMAR, FL, Jan. 16, 2019 (GLOBE NEWSWIRE) -- via...
Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans
January 14, 2019 09:00 ET
|
Generex Biotechnology Corp.
MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the...